ArcoScreen

Lausanne, Switzerland

ArcoScreen is a Swiss medtech is developing a new microfluidic discovery platform for drug screening targeting cell membrane receptors.

$100K raised

Oct 2022

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ArcoScreen raised?

ArcoScreen has raised $100K in total funding. The most recent round was Debt Financing. The last funding was announced in October 2022.

Who are ArcoScreen's investors?

ArcoScreen's investors include Venture Kick, Foundation for Innovation and Technology (FIT).

Where is ArcoScreen headquartered?

ArcoScreen is headquartered in Lausanne, Switzerland.

What does ArcoScreen do?

ArcoScreen is a Swiss medtech is developing a new microfluidic discovery platform for drug screening targeting cell membrane receptors.

What stage is ArcoScreen at?

ArcoScreen is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 12, 2022.

MLA

"ArcoScreen — Funding & Investors." VCBacked, October 12, 2022, https://www.vcbacked.co/company/arcoscreen. Accessed July 1, 2026.

APA

VCBacked. (2022). ArcoScreen — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/arcoscreen

Wikipedia (cite web)

{{cite web |title=ArcoScreen — Funding & Investors |url=https://www.vcbacked.co/company/arcoscreen |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 12, 2022.